VRTX: Vertex Pharmaceuticals Inc insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Institutional ownership (Q2 2026)
1,770 institutions reported holding $117.41B of Vertex Pharmaceuticals Inc on Form 13F (1,701 the quarter before). 174 opened a new position and 110 sold out. Shares held by institutions: +2%.
| Largest holders | Shares | Value |
|---|---|---|
| Capital World Investors | 26,115,014 | $12.97B |
| BlackRock, Inc. | 24,109,373 | $11.98B |
| Capital Research Global Investors | 19,490,637 | $9.68B |
| VANGUARD CAPITAL MANAGEMENT LLC | 16,580,713 | $8.24B |
| STATE STREET CORP | 11,871,459 | $5.90B |
| Invesco Ltd. | 8,043,052 | $4.00B |
| JPMORGAN CHASE & CO | 6,517,600 | $3.26B |
| GEODE CAPITAL MANAGEMENT, LLC | 6,017,848 | $2.98B |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4,878,987 | $2.42B |
| Capital International Investors | 4,695,144 | $2.33B |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.